Hamps Bio board to consider FY26 results on May 29

0 min read     Updated on 25 May 2026, 08:58 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Hamps Bio Limited will hold a board meeting on May 29, 2026, to approve audited financial results for the half-year and year ended March 31, 2026. The board will also consider appointing Naviwala & Associates, Surat as internal auditor for FY27.

powered bylight_fuzz_icon
41268518

*this image is generated using AI for illustrative purposes only.

Hamps Bio Limited has scheduled a board meeting on Friday, May 29, 2026, to consider and approve the audited standalone and consolidated financial results for the half-year and year ended March 31, 2026. The meeting will be held at the company's corporate office. The board will also deliberate on the appointment of Naviwala & Associates, Surat as the internal auditor for the financial year 2026-2027.

The intimation was submitted to BSE Limited in compliance with Regulation 29 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation, 2015. The agenda includes the consideration of any other business with the permission of the Chair.

Agenda Items

The board meeting will focus on the following key matters:

  • Consideration and approval of audited standalone and consolidated financial results for the half-year and year ended March 31, 2026.
  • Appointment of Naviwala & Associates, Surat as internal auditor for FY27.
  • Any other business with the permission of the Chair.

Company Details

Attribute Details
Scrip Code 544312
CIN No. L24233GJ2007PLC049692
Managing Director & Chairman Herrick Mountbaton Shah
DIN 01052316

Historical Stock Returns for Hamps Bio

1 Day5 Days1 Month6 Months1 Year5 Years
+4.96%-0.26%+3.69%+10.12%+16.68%-48.02%

How will the audited financial results for FY26 impact Hamps Bio's stock performance and investor sentiment?

What strategic initiatives or growth plans might the board discuss under 'any other business'?

Could the appointment of Naviwala & Associates as internal auditor signal a shift in the company's compliance or governance practices?

Hamps Bio Limited Receives SEBI Compliance Certificate for Q4FY26

1 min read     Updated on 14 Apr 2026, 07:18 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Hamps Bio Limited received its Q4FY26 compliance certificate under SEBI (Depositories and Participants) Regulations, 2018, issued by registrar Bigshare Services Private Limited on April 04, 2026. The certificate confirms all company shares remain in demat form with zero rematerialisation requests during the quarter ended March 31, 2026, ensuring full regulatory compliance.

powered bylight_fuzz_icon
37720127

*this image is generated using AI for illustrative purposes only.

Hamps Bio Limited has successfully obtained its quarterly compliance certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The certificate demonstrates the company's adherence to regulatory requirements governing share depositories and participant operations.

Regulatory Compliance Status

Bigshare Services Private Limited, serving as the company's Registrar and Share Transfer Agent (RTA), issued the certificate on April 04, 2026. The certificate confirms that Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 is not applicable to Hamps Bio Limited during the specified quarter.

Compliance Parameter: Status
Quarter Period: March 31, 2026
Certificate Date: April 04, 2026
Issuing Authority: Bigshare Services Private Limited
Regulation: SEBI (Depositories and Participants) Regulations, 2018

Share Holding Structure

The certificate highlights that the entire shareholding of Hamps Bio Limited remains in dematerialised (demat) form. This complete dematerialisation of shares eliminates the need for physical share certificates and ensures seamless electronic trading and transfer of securities.

During the quarter ended March 31, 2026, Bigshare Services Private Limited confirmed that no requests for rematerialisation were received from any company members. This indicates investor satisfaction with the electronic format and smooth functioning of the depository system.

Corporate Communication

Company Secretary Komal Jain (Membership No. ACS A40470) formally communicated the certificate to BSE Limited on April 14, 2026. The company has also made the certificate available on its official website at www.hampsbio.com for stakeholder access and transparency.

Company Operations

Hamps Bio Limited operates manufacturing facilities at two locations in Gujarat. Unit-1 is situated at G.I.D.C. Industrial Estate near Atul Ltd. in Ankleshwar, while Unit-2 is located at Bhatpore G.I.D.C. in Surat. The company, previously known as Hamps Bio Pvt. Ltd., maintains its corporate identification number as L24233GJ2007PLC049692.

Historical Stock Returns for Hamps Bio

1 Day5 Days1 Month6 Months1 Year5 Years
+4.96%-0.26%+3.69%+10.12%+16.68%-48.02%

What expansion plans does Hamps Bio have for its Gujarat manufacturing facilities given its strong regulatory compliance track record?

How might Hamps Bio's complete dematerialization of shares position the company for potential institutional investor interest or strategic partnerships?

Will Hamps Bio consider listing on additional stock exchanges beyond BSE given its robust compliance framework?

More News on Hamps Bio

1 Year Returns:+16.68%